Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
09/17/2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory Survival rates of patients with melanoma have drastically improved in the…
|
09/12/2023
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Last year, over 197,000 Americans were diagnosed with melanoma—and we know they won’t go through that experience alone because there…
|
09/07/2023
In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO Understanding the principles adjuvant therapy for adult cancers so we can apply this understanding…
|
08/28/2023
Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
By Mara Klecker At 52, Tricia Riffenburgh felt fit, healthy and grateful for her life. She was a successful consultant…
|
08/15/2023
Clinical Trials Catch Up
Welcome to our new interview series called Clinical Trials Catch Up, an article delivered in a question-and-answer format designed to…
|
08/08/2023
Dealing with the Emotional Rollercoaster that Follows a Melanoma Diagnosis PART II with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
What is Psychosocial oncology? What can a newly diagnosed patient expect on their first visit to a psychosocial oncologist? What…
|
08/01/2023
AIM’s Latest Newsletter: The Research Edition, July 2023
This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research. This edition features: Letter from AIM’s…
|
07/09/2023
I’ve Been Diagnosed With Melanoma…Now What? PART I with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
The test results are back. You’ve talked to the doctor and learned you have melanoma. Whether it’s your first or…
|
06/27/2023
ASCO Update 2023
What is ASCO? ASCO is the abbreviation for the American Society of Clinical Oncology, and it is simply the professional…
|
06/26/2023
Jim Zeoli Had Never Spent Much Time Thinking About Melanoma—Until He Was Diagnosed
by Mara Klecker Jim Zeoli had never spent much time thinking about melanoma before his own diagnosis at the end…
|
Recent Posts
Sep. 17, 2023
Notes from the Lab: Novel targets for immune checkpoint inhibitors
Sep. 12, 2023
Becoming a Melanoma Caregiver…Now What? PART III with guest host, Melissa Wilson, PA-C, MPAS, UPMC Hillman Cancer Center
Sep. 07, 2023
In Plain English—Neoadjuvant Therapy for Melanoma, and How We Got Here
Aug. 28, 2023
Survivor Profile: Tricia Riffenburgh, Stage IV Melanoma
Aug. 15, 2023